RX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various clinical chemistry tests.

Recall Insight

This FDA Devices action (record #Z-2059-2018) was formally reported on June 13, 2018, with the manufacturer initiating the action on May 4, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Randox Laboratories is listed as the recalling firm, operating out of Kearneysville, WV. Federal records indicate 41 analyzers units are affected.

The documented reason for this recall is: Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results. Distribution data in the federal record shows the product reached: US Distribution including Puerto Rico and the state of : West Virginia.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 8 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.